Background/Aim: This study was designed to provide further evidence for the interactions
between hydrogen sulfide (H2S) and nitric oxide (NO) in ischemia/reperfusion (I/R) injury …

The cardioprotective property of hydrogen sulfide (H 2 S) is recently reported. However,
cellular signaling cascades mediated by H 2 S are largely unclear. This study was …

Decreased circulating levels of hydrogen sulfide (H2S) are associated with higher mortality
following myocardial ischemia. This study aimed at determining the long-term dose …

Hydrogen sulfide (H2S) is believed to be involved in numerous physiological and
pathophysiological processes, and now it is recognized as the third endogenous signaling …

BACKGROUND: Hydrogen sulfide (H2S) displays anti-inflammatory and cytoprotective
activities to attenuate myocardial ischemia–reperfusion (MIR)-induced injury, but its role in …

The role of hydrogen sulfide (H2S) in myocardial infarction (MI) has not been previously
studied. We therefore investigated the effect of H2S in a rat model of MI in vivo. Animals …

The gaseous mediator hydrogen sulfide (H2S) is synthesized mainly by cystathionine γ-
lyase in the heart and plays a role in the regulation of cardiovascular homeostasis. Here we …

Hydrogen sulfide (H 2 S) is recognized to be a novel mediator after carbon monoxide and
nitric oxide in the organism. It can be produced in various mammalian tissues and exert …

Background Ischemia-reperfusion injury (IRI) is a major cause of cardiac damage following
various pathological processes. Gaseous hydrogen sulfide (H2S) is protective during IRI by …

Rationale: The recent emergence of hydrogen sulfide (H2S) as a potent cardioprotective
signaling molecule necessitates the elucidation of its cytoprotective mechanisms. Objective …